Alessio Degiovanni
Impact in
-
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Papers in
- Oncology 6
-
- Prostate Cancer Diagnosis and Treatment 2
- Prostate Cancer Treatment and Research 2
- Co-authors
- Francesco Vasuri (18 shared papers)Antonia D’Errico-Grigioni (7 shared papers)Michelangelo Fiorentino (4 shared papers)Silvia Fittipaldi (7 shared papers)Antonietta D’Errico (5 shared papers)Gianandrea Pasquinelli (10 shared papers)Francesca Giunchi (5 shared papers)Elisa Capizzi (3 shared papers)
- Journals
- Biomolecules (2 papers)PLoS ONE (2 papers)Histopathology (1 paper)The Oncologist (1 paper)Journal of Clinical Pathology (1 paper)
- Partner nations
- ItalyUnited StatesPoland
In The Last Decade
Alessio Degiovanni
24 papers receiving 366 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 56
- Aging 7
- Oncology 81
- Hepatology 20
- Pulmonary and Respiratory Medicine 72
Countries citing papers authored by Alessio Degiovanni
This map shows the geographic impact of Alessio Degiovanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessio Degiovanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessio Degiovanni more than expected).
Fields of papers citing papers by Alessio Degiovanni
This network shows the impact of papers produced by Alessio Degiovanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessio Degiovanni. The network helps show where Alessio Degiovanni may publish in the future.
Co-authors
The 25 scholars most cited alongside Alessio Degiovanni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 65 | |
| 2 | 2013 | 53 | |
| 3 | 2016 | 37 | |
| 4 | 2014 | 22 | |
| 5 | 2018 | 21 | |
| 6 | 2023 | 20 | |
| 7 | 2016 | 19 | |
| 8 | 2012 | 19 | |
| 9 | 2017 | 15 | |
| 10 | 2014 | 15 | |
| 11 | 2017 | 14 | |
| 12 | 2017 | 12 | |
| 13 | 2015 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2015 | 8 | |
| 16 | 2014 | 7 | |
| 17 | 2016 | 7 | |
| 18 | 2021 | 5 | |
| 19 | 2024 | 3 | |
| 20 | 2025 | 2 |
About Alessio Degiovanni
Alessio Degiovanni is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cell Biology and Immunology, having authored 25 papers that have together received 370 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Prostate Cancer Treatment and Research (2 papers), MicroRNA in disease regulation (2 papers), Phytochemicals and Antioxidant Activities (1 paper), Urologic and reproductive health conditions (1 paper), Cancer Genomics and Diagnostics (1 paper) and Muscle metabolism and nutrition (1 paper). The work is most often cited by research in Cancer Research (56 citations), Aging (7 citations), Oncology (81 citations), Hepatology (20 citations) and Pulmonary and Respiratory Medicine (72 citations). Alessio Degiovanni has collaborated with scholars based in Italy, United States and Poland. Frequent co-authors include Francesco Vasuri, Antonia D’Errico-Grigioni, Michelangelo Fiorentino, Silvia Fittipaldi, Antonietta D’Errico, Gianandrea Pasquinelli, Francesca Giunchi, Elisa Capizzi, Miriam Capri and Andréa Stella. Their work appears in journals such as Biomolecules, PLoS ONE, Histopathology, The Oncologist and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.